More reads
- Why Democrats reopened the debate about germline gene editing. (STAT)
- U.K. regulator opens investigation into Woodford meltdown. (Financial Times)
- There’s a fight brewing in Congress over pharma’s patents. (STAT Plus)
- Chinese 'Resident Evil' fans think this biotech company's logo looks familiar. (Kotaku)
No hay comentarios:
Publicar un comentario